CDMO Activity Tracker: Bora, PolPharma make acquisitions; Evonik, EUROAPI, Porton announce technological expansions

Data Compilation
#PharmaFlow

Pipeline Prospector Nov 2024: Trump’s HHS pick drags down jab makers’ stocks; Novartis, Merck, Roche ink billion-dollar deals

Stock Recap
#PipelineProspector

Lamivudine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

52 API Suppliers, 33 USDMF, 16 CEP/COS, 1 JDMF, 14 EU WC, 4 KDMF, 15 NDC API, 20 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

INTERMEDIATES

3 Intermediates Suppliers

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

354 FDF Dossiers, 126 FDA Orange Book, 57 Europe, 23 Canada, 7 Australia, 111 South Africa, 30 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 600MG BASE;EQ 50MG BASE;300MG, TABLET;ORAL - 150MG;200MG;300MG, TABLET;ORAL - 150MG, TABLET;ORAL - 300MG, TABLET;ORAL - 100MG;300MG;300MG, TABLET;ORAL - 300MG;300MG, TABLET;ORAL - EQ 600MG BASE;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 16 SPI Pharma, 2 Seqens, 4 DKSH, 5 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 12 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 25 BASF, 8 Beneo, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 39 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 19 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

92 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 45 Direct Compression, 33 Controlled & Modified Release, 32 Disintegrants & Superdisintegrants, 28 Thickeners and Stabilizers, 26 Solubilizers, 25 Granulation, 24 Taste Masking, 22 Co-Processed Excipients, 18 Chewable & Orodispersible Aids, 18 Parenteral, 15 Lubricants & Glidants, 15 Topical, 13 Film Formers & Plasticizers, 8 API Stability Enhancers, 8 Emulsifying Agents, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Rheology Modifiers, 3 Surfactant & Foaming Agents

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 1 STOCK RECAP #PipelineProspector, 102 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 49 Finished Drug Prices, 18 Annual Reports

MARKET PLACE

12 APIs, 10 FDF Dossiers

PATENTS & EXCLUSIVITIES

21 US Patents, 6 US Exclusivities, 20 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 4 USP, 9 Others

ANALYTICAL

1 BioAnalytical Methods, 1 Analytical Methods

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
28/11/2024	Arch Pharmalabs	India	ARCH PHARMALABS LIMITED Mumbai IN	R1-CEP 2012-362 - Rev 00	Lamivudine	2021-09-14	Valid	Chemical		2217
28/11/2024	Arene Lifesciences	India	ARENE LIFE SCIENCES PRIVATE LIMITED Sangareddy IN	CEP 2022-248 - Rev 01	Lamivudine	2024-09-18	Valid	Chemical		2217

Lamivudine

Lamivudine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

52 API Suppliers

33 USDMF

16 CEP/COS

1 JDMF

14 EU WC

4 KDMF

15 NDC API

20 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

15 Drugs in Development

INTERMEDIATES

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

354 FDF Dossiers

126 FDA Orange Book

57 Europe

23 Canada

7 Australia

111 South Africa

30 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 600MG BASE;EQ 50MG BASE;300MG

TABLET;ORAL - 150MG;200MG;300MG

TABLET;ORAL - 150MG

TABLET;ORAL - 300MG

TABLET;ORAL - 100MG;300MG;300MG

TABLET;ORAL - 300MG;300MG

TABLET;ORAL - EQ 600MG BASE;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc

16 SPI Pharma

2 Seqens

4 DKSH

5 Faran Shimi Pharmaceutical

8 Boai NKY Pharmaceuticals Ltd

12 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 ACG Worldwide

8 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

25 BASF

8 Beneo

1 Clariant

10 Corel Pharma Chem

6 DFE Pharma

2 Finar

12 Gangwal Chemicals

7 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

39 Kerry

3 Kima Chemical

6 Lonza Capsugel

15 Microlex e.U

1 Nanjing Bold Chemical

2 Nomisma Healthcare

4 Novo Excipients

4 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

19 Roquette

13 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

2 The Dow Chemical Company

2 Ulanqab Kema New Material

TABLET;ORAL - EQ 600MG BASE;300MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons